ORIC
Oric Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $1.38B
- Employees
- 104
- Latest publication
- 2026-09-29
About Oric Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and rinzimetostat formerly known as ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. It has a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,066,000USD | 0USD | 0USD |
| Research Development | 31,437,000USD | 25,856,000USD | 28,773,000USD | 30,549,000USD | 24,640,000USD | 31,970,000USD | 31,202,000USD | 28,940,000USD |
| Selling General Administrative | 8,182,000USD | 8,695,000USD | 7,898,000USD | 8,515,000USD | 8,078,000USD | 7,600,000USD | 7,116,000USD | 7,077,000USD |
| Total Operating Expenses | 39,619,000USD | 34,231,000USD | 36,671,000USD | 39,064,000USD | 32,718,000USD | 39,266,000USD | 38,318,000USD | 36,017,000USD |
| Operating Income | -39,619,000USD | -34,551,000USD | -36,671,000USD | -39,064,000USD | -32,718,000USD | -39,570,000USD | -38,318,000USD | -36,017,000USD |
| Income Before Tax | -35,767,000USD | -30,505,000USD | -32,587,000USD | -36,355,000USD | -30,021,000USD | -36,307,000USD | -34,566,000USD | -31,963,000USD |
| Net Income | -35,767,000USD | -30,505,000USD | -32,587,000USD | -36,355,000USD | -30,021,000USD | -36,307,000USD | -34,566,000USD | -31,963,000USD |
| Net Income From Continuing Ops | -35,767,000USD | -30,505,000USD | -32,587,000USD | -36,355,000USD | -30,021,000USD | -36,307,000USD | -34,566,000USD | -31,963,000USD |
| Ebit | -39,619,000USD | -30,505,000USD | -32,587,000USD | -39,064,000USD | -32,718,000USD | -36,307,000USD | -38,318,000USD | -36,017,000USD |
| Ebitda | -39,349,000USD | -30,185,000USD | -32,299,000USD | -38,754,000USD | -32,416,000USD | -36,003,000USD | -38,048,000USD | -35,745,000USD |
| Depreciation And Amortization | 270,000USD | 320,000USD | 288,000USD | 310,000USD | 302,000USD | 304,000USD | 270,000USD | 272,000USD |
| Reconciled Depreciation | 270,000USD | 320,000USD | 288,000USD | 310,000USD | 302,000USD | 304,000USD | 270,000USD | 272,000USD |
| Total Other Income Expense Net | 3,852,000USD | 4,046,000USD | 4,084,000USD | 2,709,000USD | 2,697,000USD | 3,263,000USD | 3,752,000USD | 4,054,000USD |
| Cost Of Revenue | — | 320,000USD | — | 310,000USD | 302,000USD | 304,000USD | 270,000USD | 272,000USD |
| Gross Profit | — | -320,000USD | — | -310,000USD | -302,000USD | -304,000USD | -270,000USD | -272,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -272,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 1,220,000USD | 1,107,000USD | 1,032,000USD | 966,000USD | 897,000USD | 970,000USD | 1,000,000USD | 900,000USD |
| Gross Profit | -1,220,000USD | -1,107,000USD | -1,032,000USD | -966,000USD | -897,000USD | -970,000USD | -1,000,000USD | -900,000USD |
| Research Development | 109,818,000USD | 114,072,000USD | 85,172,000USD | 61,680,000USD | 56,858,000USD | 60,764,000USD | 22,844,000USD | 19,026,000USD |
| Selling General Administrative | 33,186,000USD | 28,823,000USD | 25,608,000USD | 25,087,000USD | 22,013,000USD | 13,422,000USD | 5,725,000USD | 3,345,000USD |
| Total Operating Expenses | 141,784,000USD | 141,788,000USD | 109,748,000USD | 91,767,000USD | 78,871,000USD | 74,186,000USD | 27,569,000USD | 22,371,000USD |
| Operating Income | -143,004,000USD | -142,895,000USD | -110,780,000USD | -91,767,000USD | -78,871,000USD | -74,186,000USD | -28,569,000USD | -22,371,000USD |
| Income Before Tax | -129,468,000USD | -127,847,000USD | -100,697,000USD | -89,122,000USD | -78,715,000USD | -73,703,000USD | -26,883,000USD | -21,363,000USD |
| Net Income | -129,468,000USD | -127,847,000USD | -100,697,000USD | -89,122,000USD | -77,677,000USD | -73,703,000USD | -26,883,000USD | -21,363,000USD |
| Net Income From Continuing Ops | -129,468,000USD | -127,847,000USD | -100,697,000USD | -89,122,000USD | -78,715,000USD | -73,703,000USD | -26,883,000USD | -21,363,000USD |
| Ebit | -129,468,000USD | -127,847,000USD | -110,780,000USD | -86,767,000USD | -78,871,000USD | -49,343,000USD | -26,883,000USD | -21,363,000USD |
| Ebitda | -128,248,000USD | -126,740,000USD | -109,748,000USD | -85,801,000USD | -77,974,000USD | -48,373,000USD | -25,883,000USD | -20,463,000USD |
| Depreciation And Amortization | 1,220,000USD | 1,107,000USD | 1,032,000USD | 966,000USD | 897,000USD | 970,000USD | 1,000,000USD | 900,000USD |
| Reconciled Depreciation | 1,220,000USD | 1,107,000USD | 1,032,000USD | 966,000USD | 897,000USD | 970,000USD | 1,028,000USD | 903,000USD |
| Total Other Income Expense Net | 13,536,000USD | 15,048,000USD | 10,083,000USD | 2,645,000USD | 156,000USD | 483,000USD | 1,686,000USD | 1,008,000USD |
| Unclassified Operating Expenses | — | — | — | 5,000,000USD | — | — | — | — |
| Interest Income | — | — | — | 2,645,000USD | 141,000USD | 306,000USD | 1,397,000USD | 775,000USD |
| Interest Expense | — | — | — | 2,645,000USD | 141,000USD | 306,000USD | 1,686,000USD | 1,008,000USD |
| Net Interest Income | — | — | — | 2,645,000USD | 141,000USD | 306,000USD | 1,397,000USD | 775,000USD |
| Income Tax Expense | — | — | — | 2,355,000USD | -1,038,000USD | 23,567,000USD | -1,397,000USD | -1,008,000USD |
| Net Income Applicable To Common Shares | — | — | — | -89,122,000USD | -78,715,000USD | -73,703,000USD | -26,883,000USD | -21,363,000USD |
| Non Operating Income Net Other | — | — | — | — | 15,000USD | 177,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 404,685,000USD | 436,762,000USD | 411,002,000USD | 431,192,000USD | 346,857,000USD | 242,858,000USD | 274,142,000USD | 302,070,000USD |
| Cash And Equivalents | 37,483,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 273,695,000USD | 290,233,000USD | 288,466,000USD | 295,594,000USD | 291,124,000USD | 211,433,000USD | 262,250,000USD | 279,428,000USD |
| Other Current Assets | 8,934,000USD | 8,301,000USD | 6,978,000USD | 8,454,000USD | 8,611,000USD | 7,710,000USD | 6,290,000USD | 7,059,000USD |
| Other Non Current Assets | 5,949,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 23,429,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 20,756,000USD | 17,771,000USD | 20,417,000USD | 20,179,000USD | 18,050,000USD | 17,617,000USD | 24,846,000USD | 21,248,000USD |
| Other Current Liabilities | 16,883,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 2,673,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 381,256,000USD | 415,557,000USD | 384,362,000USD | 406,919,000USD | 323,995,000USD | 219,738,000USD | 243,122,000USD | 273,994,000USD |
| Total Equity Including Noncontrolling Interest | 381,256,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,242,000USD | 2,147,000USD | 9,073,000USD | 2,559,000USD | 2,762,000USD | 3,021,000USD | 2,924,000USD | 3,091,000USD |
| Accounts Payable | 3,873,000USD | 2,895,000USD | 3,824,000USD | 2,900,000USD | 3,130,000USD | 5,160,000USD | 1,548,000USD | 4,249,000USD |
| Common Stock | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 9,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -769,501,000USD | -728,009,000USD | -692,242,000USD | -661,737,000USD | -629,150,000USD | -592,795,000USD | -562,774,000USD | -526,467,000USD |
| Accumulated Other Comprehensive Income | -1,018,000USD | -290,000USD | 786,000USD | 615,000USD | 187,000USD | 209,000USD | 379,000USD | 722,000USD |
| Total Liab | — | 21,205,000USD | 26,640,000USD | 24,273,000USD | 22,862,000USD | 23,120,000USD | 31,020,000USD | 28,076,000USD |
| Other Current Liab | — | 14,876,000USD | 13,263,000USD | 13,978,000USD | 11,647,000USD | 9,244,000USD | 20,115,000USD | 13,878,000USD |
| Capital Stock | — | 11,000USD | 11,000USD | 11,000USD | 9,000USD | 7,000USD | 7,000USD | 7,000USD |
| Cash | — | 56,396,000USD | 45,669,000USD | 49,668,000USD | 75,864,000USD | 49,334,000USD | 59,406,000USD | 44,230,000USD |
| Cash And Short Term Investments | — | 281,932,000USD | 281,488,000USD | 287,140,000USD | 282,513,000USD | 203,723,000USD | 255,960,000USD | 272,369,000USD |
| Net Debt | — | -56,396,000USD | -34,117,000USD | -46,367,000USD | -72,591,000USD | -46,121,000USD | -56,223,000USD | -41,109,000USD |
| Long Term Investments | — | 137,779,000USD | 110,762,000USD | 125,908,000USD | 45,216,000USD | 20,039,000USD | 0USD | 9,998,000USD |
| Short Term Investments | — | 225,536,000USD | 235,819,000USD | 237,472,000USD | 206,649,000USD | 154,389,000USD | 196,554,000USD | 228,139,000USD |
| Property Plant Equipment Gross | — | 10,068,000USD | 10,066,000USD | 10,720,000USD | 10,758,000USD | 10,797,000USD | 10,400,000USD | 10,302,000USD |
| Common Stock Shares Outstanding | — | 105,472,766shares | 87,793,801shares | 98,953,331shares | 78,126,257shares | 71,040,580shares | 70,652,012shares | 70,542,684shares |
| Non Current Assets Total | — | 146,529,000USD | 122,536,000USD | 135,598,000USD | 55,733,000USD | 31,425,000USD | 11,892,000USD | 22,642,000USD |
| Non Current Liabilities Total | — | 3,434,000USD | 6,222,999USD | 4,094,000USD | 4,812,000USD | 5,503,000USD | 6,174,000USD | 6,828,000USD |
| Non Current Liabilities Other | — | 3,434,000USD | 4,111,000USD | 4,094,000USD | 4,812,000USD | 5,503,000USD | 6,174,000USD | 6,828,000USD |
| Non Currrent Assets Other | — | 6,603,000USD | 98,000USD | 7,131,000USD | 7,755,000USD | 8,365,000USD | 8,968,000USD | 9,553,000USD |
| Net Working Capital | — | 272,462,000USD | 268,049,000USD | 275,415,000USD | 273,074,000USD | 193,816,000USD | 237,404,000USD | 258,180,000USD |
| Unclassified Equity | — | 1,143,834,000USD | 1,075,796,000USD | 1,068,019,000USD | 952,940,000USD | 812,310,000USD | 805,503,000USD | 799,725,000USD |
| Short Term Debt | — | — | 3,330,000USD | 3,301,000USD | 3,273,000USD | 3,213,000USD | 3,183,000USD | 3,121,000USD |
| Short Long Term Debt Total | — | — | 11,551,998USD | 3,301,000USD | 3,273,000USD | 3,213,000USD | 3,183,000USD | 3,121,000USD |
| Unclassified Non Current Assets | — | — | 2,603,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | 2,111,999USD | — | — | — | — | — |
| Other Assets | — | — | — | — | — | — | -2,587,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 411,002,000USD | 274,142,000USD | 254,686,000USD | 250,359,000USD | 298,642,000USD | 298,997,000USD | 94,093,000USD | 46,734,000USD |
| Other Current Assets | 6,978,000USD | 6,290,000USD | 4,410,000USD | 4,185,000USD | 3,543,000USD | 3,097,000USD | 840,000USD | 1,088,000USD |
| Total Liab | 26,640,000USD | 31,020,000USD | 30,598,000USD | 28,008,000USD | 25,666,000USD | 9,221,000USD | 6,119,000USD | 111,160,000USD |
| Total Stockholder Equity | 384,362,000USD | 243,122,000USD | 224,088,000USD | 222,351,000USD | 272,976,000USD | 289,776,000USD | 87,974,000USD | -64,426,000USD |
| Other Current Liab | 13,263,000USD | 20,115,000USD | 16,762,000USD | 11,409,000USD | 11,339,000USD | 8,245,000USD | 5,202,000USD | 1,712,000USD |
| Common Stock | 11,000USD | 7,000USD | 6,000USD | 5,000USD | 4,000USD | 4,000USD | 2,000USD | 1,000USD |
| Capital Stock | 11,000USD | 7,000USD | 6,000USD | 5,000USD | 4,000USD | 4,000USD | 2,000USD | 0USD |
| Retained Earnings | -692,242,000USD | -562,774,000USD | -434,927,000USD | -334,230,000USD | -245,108,000USD | -166,393,000USD | -92,690,000USD | -65,807,000USD |
| Cash | 45,669,000USD | 59,406,000USD | 23,384,000USD | 66,840,000USD | 226,006,000USD | 78,446,000USD | 89,159,000USD | 42,636,000USD |
| Cash And Short Term Investments | 281,488,000USD | 255,960,000USD | 208,187,000USD | 206,272,000USD | 236,979,000USD | 293,600,000USD | 89,159,000USD | 42,636,000USD |
| Total Current Assets | 288,466,000USD | 262,250,000USD | 212,597,000USD | 210,457,000USD | 240,522,000USD | 296,697,000USD | 89,999,000USD | 43,724,000USD |
| Total Current Liabilities | 20,417,000USD | 24,846,000USD | 20,458,000USD | 15,388,000USD | 15,151,000USD | 9,002,000USD | 5,354,000USD | 2,596,000USD |
| Net Debt | -34,117,000USD | -56,223,000USD | -13,171,000USD | -54,742,000USD | -224,080,000USD | -78,446,000USD | -89,159,000USD | -42,636,000USD |
| Short Term Debt | 3,330,000USD | 3,183,000USD | 2,752,000USD | 2,659,000USD | 1,926,000USD | 546,000USD | 495,000USD | — |
| Short Long Term Debt Total | 11,551,998USD | 3,183,000USD | 10,213,000USD | 12,098,000USD | 1,926,000USD | — | — | — |
| Long Term Investments | 110,762,000USD | 0USD | 26,852,000USD | 21,951,000USD | 43,386,000USD | 0USD | — | — |
| Short Term Investments | 235,819,000USD | 196,554,000USD | 184,803,000USD | 139,432,000USD | 10,973,000USD | 215,154,000USD | — | — |
| Accounts Payable | 3,824,000USD | 1,548,000USD | 944,000USD | 1,320,000USD | 1,886,000USD | 757,000USD | 152,000USD | 446,000USD |
| Property Plant Equipment Net | 9,073,000USD | 2,924,000USD | 12,006,000USD | 14,253,000USD | 2,413,000USD | 1,981,000USD | 2,241,000USD | 2,514,000USD |
| Property Plant Equipment Gross | 10,066,000USD | 10,400,000USD | 9,356,000USD | 9,046,000USD | 7,402,000USD | 1,981,000USD | 2,241,000USD | 2,514,000USD |
| Accumulated Other Comprehensive Income | 786,000USD | 379,000USD | 258,000USD | -1,291,000USD | -103,000USD | -31,000USD | -178,058,000USD | -2,578,000USD |
| Common Stock Shares Outstanding | 87,793,801shares | 69,727,940shares | 51,450,848shares | 39,655,260shares | 37,954,280shares | 21,942,476shares | 29,903,039shares | 1,734,115shares |
| Non Current Assets Total | 122,536,000USD | 11,892,000USD | 42,089,000USD | 39,902,000USD | 58,120,000USD | 2,300,000USD | 4,094,000USD | 3,010,000USD |
| Non Current Liabilities Total | 6,222,999USD | 6,174,000USD | 10,140,000USD | 12,620,000USD | 10,515,000USD | 219,000USD | 765,000USD | 108,564,000USD |
| Non Current Liabilities Other | 4,111,000USD | 6,174,000USD | 7,461,000USD | 9,439,000USD | 10,515,000USD | 219,000USD | — | 47,000USD |
| Non Currrent Assets Other | 98,000USD | 8,968,000USD | 61,000USD | 49,000USD | 12,321,000USD | 319,000USD | 1,853,000USD | 496,000USD |
| Net Working Capital | 268,049,000USD | 237,404,000USD | 192,139,000USD | 195,069,000USD | 225,371,000USD | 287,695,000USD | 84,645,000USD | 41,128,000USD |
| Unclassified Non Current Assets | 2,603,000USD | — | 3,170,000USD | 3,132,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | 2,111,999USD | — | 2,679,000USD | 3,181,000USD | — | — | -1,343,000USD | 107,219,000USD |
| Unclassified Equity | 1,075,796,000USD | 805,503,000USD | 658,745,000USD | 557,862,000USD | 518,179,000USD | 456,192,000USD | 358,718,000USD | 3,958,000USD |
| Other Assets | — | — | — | 517,000USD | 521,000USD | 319,000USD | 0USD | 496,000USD |
| Net Tangible Assets | — | — | — | 222,351,000USD | 272,976,000USD | 289,776,000USD | -90,084,000USD | -64,426,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 219,000USD | 1,343,000USD | — |
| Other Liab | — | — | — | — | — | 219,000USD | 765,000USD | 1,298,000USD |
| Current Deferred Revenue | — | — | — | — | — | 546,000USD | 495,000USD | 438,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -1,092,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -35,767,000USD | -30,505,000USD | -32,587,000USD | -36,355,000USD | -30,021,000USD | -36,307,000USD | -34,566,000USD | -31,963,000USD |
| Depreciation | 270,000USD | 320,000USD | 288,000USD | 310,000USD | 302,000USD | 304,000USD | 270,000USD | 272,000USD |
| Stock Based Compensation | 6,898,000USD | 6,278,000USD | 5,631,000USD | 6,574,000USD | 6,554,000USD | 5,203,000USD | 5,056,000USD | 4,996,000USD |
| Other Non Cash Items | 162,000USD | -240,000USD | -587,000USD | -591,000USD | 5,430,000USD | -1,634,000USD | -1,946,000USD | -2,296,000USD |
| Change In Working Capital | -4,001,000USD | 1,664,000USD | 2,143,000USD | -780,000USD | -8,486,000USD | 4,380,000USD | 2,389,000USD | 3,366,000USD |
| Total Cash From Operating Activities | -32,438,000USD | -22,483,000USD | -25,112,000USD | -30,842,000USD | -32,775,000USD | -28,054,000USD | -28,797,000USD | -25,625,000USD |
| Capital Expenditures | -2,000USD | -387,000USD | -35,000USD | -63,000USD | -387,000USD | -219,000USD | -418,000USD | -333,000USD |
| Free Cash Flow | -32,440,000USD | -22,870,000USD | -25,147,000USD | -30,905,000USD | -33,162,000USD | -28,273,000USD | -29,215,000USD | -25,958,000USD |
| Investments | -17,973,000USD | 17,211,000USD | -110,535,000USD | -76,930,000USD | 22,450,000USD | 42,655,000USD | 23,070,000USD | 18,280,000USD |
| Total Cashflows From Investing Activities | -17,975,000USD | 16,984,000USD | -110,535,000USD | -76,930,000USD | 22,450,000USD | 42,655,000USD | 23,070,000USD | 18,280,000USD |
| Total Cash From Financing Activities | 61,140,000USD | 1,500,000USD | 109,451,000USD | 134,302,000USD | 253,000USD | 575,000USD | 126,000USD | 816,000USD |
| Issuance Of Capital Stock | 60,881,000USD | 0USD | 110,444,000USD | 133,925,000USD | 0USD | 0USD | 0USD | 0USD |
| Change In Cash | 10,727,000USD | -3,999,000USD | -26,196,000USD | 26,530,000USD | -10,072,000USD | 15,176,000USD | -5,601,000USD | -6,529,000USD |
| Begin Period Cash Flow | 46,160,000USD | 50,159,000USD | 76,355,000USD | 49,825,000USD | 59,406,000USD | 44,230,000USD | 50,322,000USD | 56,360,000USD |
| End Period Cash Flow | 56,887,000USD | 46,160,000USD | 50,159,000USD | 76,355,000USD | 49,334,000USD | 59,406,000USD | 44,721,000USD | 49,831,000USD |
| Other Cashflows From Investing Activities | -2,000USD | 223,000USD | -485,000USD | — | -387,000USD | — | -969,000USD | — |
| Other Cashflows From Financing Activities | -993,000USD | 1,500,000USD | -993,000USD | 377,000USD | -242,000USD | 125,575,000USD | 126,000USD | 816,000USD |
| Unclassified Financing Cash Flow | 1,252,000USD | — | — | — | — | -125,000,000USD | 10,951,216,000USD | -10,951,216,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -6,554,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | — | -10,951,216,000USD | 10,951,216,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | 1,387,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -129,467,999USD | -127,847,000USD | -100,697,000USD | -89,122,000USD | -78,715,000USD | -73,703,000USD | -26,883,000USD | -21,363,000USD |
| Depreciation | 1,220,000USD | 1,107,000USD | 1,032,000USD | 966,000USD | 897,000USD | 970,000USD | 1,028,000USD | 903,000USD |
| Stock Based Compensation | 25,037,000USD | 20,213,000USD | 15,226,000USD | 14,460,000USD | 12,853,000USD | 5,278,000USD | 1,094,000USD | 469,000USD |
| Other Non Cash Items | 20,339,999USD | -8,103,000USD | -6,147,000USD | -1,002,000USD | 1,351,000USD | 19,843,000USD | 8,000USD | 15,000USD |
| Change In Working Capital | -5,459,000USD | 1,968,000USD | 4,898,000USD | -445,000USD | 4,073,000USD | 2,045,000USD | 1,220,000USD | -707,000USD |
| Total Cash From Operating Activities | -113,367,000USD | -112,662,000USD | -85,688,000USD | -75,143,000USD | -59,541,000USD | -45,268,000USD | -23,533,000USD | -20,683,000USD |
| Capital Expenditures | -712,000USD | -1,188,000USD | -849,000USD | -2,078,000USD | -939,000USD | -667,000USD | -768,000USD | -525,000USD |
| Free Cash Flow | -114,079,000USD | -113,850,000USD | -86,537,000USD | -77,221,000USD | -60,480,000USD | -45,935,000USD | -24,301,000USD | -21,208,000USD |
| Investments | -147,319,000USD | 22,137,000USD | -43,403,000USD | -107,170,000USD | 159,374,000USD | -215,959,000USD | -215,485,000USD | -508,000USD |
| Total Cashflows From Investing Activities | -148,031,000USD | 22,137,000USD | -43,403,000USD | -109,248,000USD | 158,435,000USD | -215,959,000USD | -768,000USD | -508,000USD |
| Total Cash From Financing Activities | 247,661,000USD | 126,547,000USD | 85,658,000USD | 25,225,000USD | 49,134,000USD | 250,514,000USD | 70,824,000USD | 38,008,000USD |
| Issuance Of Capital Stock | 244,369,000USD | 125,000,000USD | 85,000,000USD | 25,000,000USD | 50,000,000USD | 271,308,000USD | 70,792,000USD | 37,929,000USD |
| Change In Cash | -13,737,000USD | 36,022,000USD | -43,433,000USD | -159,166,000USD | 148,028,000USD | -10,713,000USD | 46,523,000USD | 16,817,000USD |
| Begin Period Cash Flow | 59,897,000USD | 23,875,000USD | 67,308,000USD | 226,474,000USD | 78,446,000USD | 89,159,000USD | 42,636,000USD | 25,819,000USD |
| End Period Cash Flow | 46,160,000USD | 59,897,000USD | 23,875,000USD | 67,308,000USD | 226,474,000USD | 78,446,000USD | 89,159,000USD | 42,636,000USD |
| Other Cashflows From Investing Activities | -712,000USD | -1,188,000USD | — | -2,078,000USD | -1,375,000USD | 193,000USD | 193,000USD | 17,000USD |
| Other Cashflows From Financing Activities | 245,264,000USD | 1,547,000USD | 658,000USD | 225,000USD | -866,000USD | -20,794,000USD | 70,824,000USD | 38,008,000USD |
| Unclassified Operating Cash Flow | -25,037,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -241,972,000USD | — | — | 24,455,000USD | — | — | -70,923,000USD | -38,008,000USD |
| Unclassified Investing Cash Flow | — | 2,376,000USD | — | 2,078,000USD | — | — | 215,292,000USD | — |
| Change To Liabilities | — | — | — | -1,475,000USD | 2,931,000USD | 4,303,000USD | 986,000USD | -410,000USD |
| Sale Purchase Of Stock | — | — | — | 545,000USD | 50,986,000USD | 271,751,000USD | 70,923,000USD | 38,008,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -159,166,000USD | 148,028,000USD | -10,713,000USD | — | — |
| Change To Account Receivables | — | — | — | — | — | 193,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.